127 related articles for article (PubMed ID: 1374681)
1. In vivo circumvention of human colon carcinoma resistance to bleomycin.
Jani JP; Mistry JS; Morris G; Davies P; Lazo JS; Sebti SM
Cancer Res; 1992 May; 52(10):2931-7. PubMed ID: 1374681
[TBL] [Abstract][Full Text] [Related]
2. Metabolic inactivation: a mechanism of human tumor resistance to bleomycin.
Sebti SM; Jani JP; Mistry JS; Gorelik E; Lazo JS
Cancer Res; 1991 Jan; 51(1):227-32. PubMed ID: 1703034
[TBL] [Abstract][Full Text] [Related]
3. In vivo sensitization of human lung carcinoma to bleomycin by the cysteine proteinase inhibitor E-64.
Jani JP; Mistry JS; Morris G; Lazo JS; Sebti SM
Oncol Res; 1992; 4(2):59-63. PubMed ID: 1375852
[TBL] [Abstract][Full Text] [Related]
4. Cysteine proteinase inhibitors and bleomycin-sensitive and -resistant cells.
Morris G; Mistry JS; Jani JP; Sebti SM; Lazo JS
Biochem Pharmacol; 1991 Jun; 41(11):1559-66. PubMed ID: 1710457
[TBL] [Abstract][Full Text] [Related]
5. Plasma and pulmonary pharmacokinetics of bleomycin in murine strains that are sensitive and resistant to bleomycin-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1988 Dec; 247(3):1052-8. PubMed ID: 2462625
[TBL] [Abstract][Full Text] [Related]
6. Pulmonary fate of [3H]bleomycin A2 in mice.
Lazo JS; Pham ET
J Pharmacol Exp Ther; 1984 Jan; 228(1):13-8. PubMed ID: 6198509
[TBL] [Abstract][Full Text] [Related]
7. Characteristics of bleomycin-resistant phenotypes of human cell sublines and circumvention of bleomycin resistance by liblomycin.
Lazo JS; Braun ID; Labaree DC; Schisselbauer JC; Meandzija B; Newman RA; Kennedy KA
Cancer Res; 1989 Jan; 49(1):185-90. PubMed ID: 2461797
[TBL] [Abstract][Full Text] [Related]
8. Yeast cysteine proteinase gene ycp1 induces resistance to bleomycin in mammalian cells.
Pei Z; Calmels TP; Creutz CE; Sebti SM
Mol Pharmacol; 1995 Oct; 48(4):676-81. PubMed ID: 7476893
[TBL] [Abstract][Full Text] [Related]
9. Acute pulmonary toxicity of bleomycin: DNA scission and matrix protein mRNA levels in bleomycin-sensitive and -resistant strains of mice.
Harrison JH; Hoyt DG; Lazo JS
Mol Pharmacol; 1989 Aug; 36(2):231-8. PubMed ID: 2475758
[TBL] [Abstract][Full Text] [Related]
10. Transgenic mice expressing the Sh ble bleomycin resistance gene are protected against bleomycin-induced pulmonary fibrosis.
Weinbach J; Camus A; Barra J; Dumont P; Julian M; Cros S; Babinet C; Tiraby G
Cancer Res; 1996 Dec; 56(24):5659-65. PubMed ID: 8971172
[TBL] [Abstract][Full Text] [Related]
11. Lidocaine potentiation of bleomycin A2 cytotoxicity and DNA strand breakage in L1210 and human A-253 cells.
Lazo JS; Braun ID; Meandzija B; Kennedy KA; Pham ET; Smaldone LF
Cancer Res; 1985 May; 45(5):2103-9. PubMed ID: 2580616
[TBL] [Abstract][Full Text] [Related]
12. Studies of the effects of alpha-difluoromethylornithine and ethanol on the pathogenesis of bleomycin-induced pulmonary fibrosis in mice.
Frost SB; Rakieten N; Raisfeld-Danse IH
Toxicol Appl Pharmacol; 1983 Dec; 71(3):307-15. PubMed ID: 6197767
[TBL] [Abstract][Full Text] [Related]
13. Experimental studies on the radiation-modifying effect of bleomycin in malignant and normal mouse tissue in vivo.
Molin J; Søgaard PE; Overgaard J
Cancer Treat Rep; 1981; 65(7-8):583-9. PubMed ID: 6166372
[TBL] [Abstract][Full Text] [Related]
14. Glucagon like peptide-1 attenuates bleomycin-induced pulmonary fibrosis, involving the inactivation of NF-κB in mice.
Gou S; Zhu T; Wang W; Xiao M; Wang XC; Chen ZH
Int Immunopharmacol; 2014 Oct; 22(2):498-504. PubMed ID: 25111852
[TBL] [Abstract][Full Text] [Related]
15. Further characterization of bleomycin-resistant HeLa cells and analysis of resistance mechanism.
Urade M; Sugi M; Matsuya T
Jpn J Cancer Res; 1988 Apr; 79(4):491-500. PubMed ID: 2454906
[TBL] [Abstract][Full Text] [Related]
16. Substrate specificity of bleomycin hydrolase.
Sebti SM; DeLeon JC; Ma LT; Hecht SM; Lazo JS
Biochem Pharmacol; 1989 Jan; 38(1):141-7. PubMed ID: 2462878
[TBL] [Abstract][Full Text] [Related]
17. Bleomycin-induced pulmonary fibrosis is independent of eosinophils.
Hao H; Cohen DA; Jennings CD; Bryson JS; Kaplan AM
J Leukoc Biol; 2000 Oct; 68(4):515-21. PubMed ID: 11037973
[TBL] [Abstract][Full Text] [Related]
18. Murine strain differences in acute lung injury and activation of poly(ADP-ribose) polymerase by in vitro exposure of lung slices to bleomycin.
Hoyt DG; Lazo JS
Am J Respir Cell Mol Biol; 1992 Dec; 7(6):645-51. PubMed ID: 1280451
[TBL] [Abstract][Full Text] [Related]
19. High dose continuous infusion of bleomycin in mice: a new model for drug-induced pulmonary fibrosis.
Harrison JH; Lazo JS
J Pharmacol Exp Ther; 1987 Dec; 243(3):1185-94. PubMed ID: 2447265
[TBL] [Abstract][Full Text] [Related]
20. Bleomycin hydrolase activity and cytotoxicity in human tumors.
Lazo JS; Boland CJ; Schwartz PE
Cancer Res; 1982 Oct; 42(10):4026-31. PubMed ID: 6179595
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
